Radboud Annals of Medical Students

RAMS

  • Home
  • News
    • Newsletter archive
  • About
    • RAMS
    • The Board
      • The General Board
        • The General Board (2021-2022)
        • Previous General Boards
      • The Editorial Board
        • The Editorial Board (2021-2022)
        • Previous Editorial Boards
    • The Supervisory Board
    • Reviewers and Editors
    • RAMS Committees
      • Symposium Committee
      • Masterclass Committee
  • Editions
    • 2021-2022
      • Twentieth Edition – September 2021
      • Twentyfirst Edition – December 2021
      • Twenty second Edition – March 2022
    • 2020-2021
      • Sixteenth edition – September 2020
      • Seventeenth edition – December 2020
      • Eighteenth edition – March 2021
      • Nineteenth Edition – June 2021
    • 2019-2020
      • Fourteenth edition – December 2019
      • Fifteenth edition – April 2020
      • Sixteenth edition – September 2020
    • 2018-2019
      • Eleventh Edition – September 2018
      • Twelfth Edition – January 2019
      • Thirteenth edition – May 2019
    • 2017 – 2018
      • Ninth Edition – November 2017
      • Tenth Edition – February 2018
    • 2016-2017
      • Sixth Edition – November 2016
      • Seventh Edition – March 2017
      • Eighth Edition – July 2017
    • 2015-2016
      • Third Edition – November 2015
      • Fourth Edition – March 2016
      • Fifth Edition – June 2016
    • 2014-2015
      • Pilot Edition – June 2014
      • First Edition – January 2015
      • Second Edition – June 2015
  • For Authors
    • Submit your Article
    • Research internship
  • For Supervisors
  • For Reviewers
  • Contact
  • Privacy policy
Je bent hier: Home / News / What to do when antibiotics are failing?

What to do when antibiotics are failing?

4 februari 2018 by Rams

By Guus Veldkamp

About 100 years ago, the world was a very different place. The average life expectancy in the industrialized world was 46 for men and 48 for women. In the Netherlands the average is now 82 years, according to the CBS. This difference is huge. Two big contributors to this change are suggested to be improved sanitation and the rise of pharmaceutical antibiotics[1-3]. The latter must have saved millions of lives; infectious diseases that were once feared, have now become easily treatable. Unfortunately, this might not last forever. Antibiotic resistance is becoming a major threat to the current medical treatment of common infectious diseases[4]. There are, however, suggestions for alternatives for antibiotics, with a return to bacteriophage therapy as one of the more popular suggestions.
Bacteriophage therapy was something I had personally never heard of, until a recent episode of “Dokters van Morgen” brought it to my attention[5]. In this episode, they explained what it was, but why it is hardly known in western medicine was also discussed.
Basically, bacteriophages are virus-like compounds that target a specific bacterium or group of bacteria. They reproduce inside the bacterial host, killing it in the process, while remaining harmless to other bacteria or organisms. Bacteriophages are the most common organisms on earth and play a key role in regulating bacterial populations.
Using bacteriophages for therapeutic purposes is not a recent development, but there is a recent increase in interest in them. In the pre-antibiotics era they were investigated but the results were mixed and the arrival of antibiotics in the 1940’s secured their dismissal. In contrast to bacteriophages, antibiotics can target a whole array of different bacteria and are therefore significantly easier to use and develop. In addition, antibiotics are more effective against infections of unknown origin.
Unfortunately, antibiotics are not perfect. The biggest problem is obviously antibiotic resistance. Furthermore, antibiotics have many known side effects, like nephrotoxicity or ototoxicity. They can induce anaphylactic reactions and they target beneficial bacteria in the gut microbiome as well. Bacteriophages are, theoretically, safer than antibiotics because they target the harmful bacteria and nothing else. However, there is a lack of clinical trials to prove this. Most importantly, bacteriophages are not susceptible to antibiotic resistance and are naturally able to evolve their own mechanisms to overcome bacteriophage resistance[6].
Since the problem of antibiotic resistance is only going to grow, bacteriophage therapy might just be worth considering. There are still some technical difficulties to overcome, but perhaps it becomes a healthcare-revolution, as the introduction of antibiotics was 70 years ago. This time without the problem of resistance, I hope.

 

[1] Derek M Lin, Britt Koskella, and Henry C Lin. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017 Aug 6; 8(3): 162–173.
[2] South-East Asia Regional Office. (2018). Water, Sanitation and Hygiene: An essential ally in a superbug age. Available at: http://www.searo.who.int/mediacentre/features/2017/water-sanitation-and-hygiene-an-essential-ally-in-a-superbug-age/en/ [Accessed 17 Jan. 2018].
[3] World Health Organization. Antimicrobial resistance global report on surveillance. Geneva: Switzerland; 2014.
[4] World Health Organization. (2018). Antimicrobial resistance. Available at: http://www.who.int/mediacentre/factsheets/fs194/en/ [Accessed 17 Jan. 2018].
[5] Dokters van Morgen: uitzending 24 oktober 2017. AVROTROS. Available at: https://zorgnu.avrotros.nl/uitzendingen/24-10-2017/
[6] Koskella B, Brockhurst MA. Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS Microbiol Rev. 2014;38:916–931.

Categorie: News, Uncategorized

RAMS Newsletter

RAMS complies to the GDPR. By submitting your e-mail address to us you agree with our Privacy Policy.

Social Media


Sponsors & Partners

  • Brian Gardner
  • Lauren Mancke
  • Nathan Rice
  • Nick Croft
  • Rafal Tomal
  • Ron Rennick
© Copyright 2014 RADBOUD ANNALS OF MEDICAL STUDENTS · All Rights Reserved · Powered by PLatform11
Beheer cookie toestemming

Om de beste ervaringen te bieden, gebruiken wij technologieën zoals cookies om informatie over je apparaat op te slaan en/of te raadplegen. Door in te stemmen met deze technologieën kunnen wij gegevens zoals surfgedrag of unieke ID's op deze site verwerken. Als je geen toestemming geeft of uw toestemming intrekt, kan dit een nadelige invloed hebben op bepaalde functies en mogelijkheden.

Functioneel Altijd actief
De technische opslag of toegang is strikt noodzakelijk voor het legitieme doel het gebruik mogelijk te maken van een specifieke dienst waarom de abonnee of gebruiker uitdrukkelijk heeft gevraagd, of met als enig doel de uitvoering van de transmissie van een communicatie over een elektronisch communicatienetwerk.
Voorkeuren
De technische opslag of toegang is noodzakelijk voor het legitieme doel voorkeuren op te slaan die niet door de abonnee of gebruiker zijn aangevraagd.
Statistieken
De technische opslag of toegang die uitsluitend voor statistische doeleinden wordt gebruikt. De technische opslag of toegang die uitsluitend wordt gebruikt voor anonieme statistische doeleinden. Zonder dagvaarding, vrijwillige naleving door uw Internet Service Provider, of aanvullende gegevens van een derde partij, kan informatie die alleen voor dit doel wordt opgeslagen of opgehaald gewoonlijk niet worden gebruikt om je te identificeren.
Marketing
De technische opslag of toegang is nodig om gebruikersprofielen op te stellen voor het verzenden van reclame, of om de gebruiker op een website of over verschillende websites te volgen voor soortgelijke marketingdoeleinden.
Beheer opties Beheer diensten Beheer leveranciers Lees meer over deze doeleinden
Bekijk voorkeuren
{title} {title} {title}